GPT and steatosis: The levels of transaminases decreased in patients with or without steatosis, including ALT (45.6 ± 50.8 U/L to 20.3 ± 4.5 U/L in patients with steatosis, p < 0.0001, and 57.78 ± 42.1 U/L to 19.4 ± 12.5 U/L in patients without steatosis, p < 0.0001, respectively); AST (36.3 ± 35.6 U/L to 18.3 ± 4.4 U/L, p < 0.0001, and 71.3 ± 58.7 U/L to 21.8 ± 10.8 U/L, p < 0.0001, respectively); and alkaline phosphatase (81.4 ± 42.1 U/L to 60.8 ± 24.5 U/L, p = 0.01, and 79.5 ± 22.8 U/L to 61.2 ± 18.4 U/L, p = 0.05).